TickerFacts.

Lucid Diagnostics Inc. (LUCD): Cost of Revenue

Annual figures by period end, from SEC filings.

$6.67M
Year ended 2025-12-31
$6.63M
Trailing 12 months to 2026-06-30
$7.10M2021-12-31: $585.0K2024-12-31: $7.10M2025-12-31: $6.67M$6.67M
2021-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$6.67M-6.0%2026-03-25, From 2025-01-01
2024-12-31$7.10Mn/a2026-03-25, From 2024-01-01
No annual figure between 2021-12-31 and 2024-12-31.
2021-12-31$585.0Kn/a2022-04-06, From 2021-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Lucid Diagnostics Inc. (LUCD)2025-12-31$6.67M-6.0%
Picard Medical, Inc. (PMI)2025-12-31$5.14M+14.2%
Intelligent Bio Solutions Inc. (INBS)2026-06-30$2.17M+19.9%
Tenon Medical, Inc. (TNON)2025-12-31$1.59M+1.3%
IceCure Medical Ltd. (ICCM)2025-12-31$2.15M+17.0%
Encision Inc (ECIA)2025-03-31$3.04M-11.8%
Nuo Therapeutics, Inc. (AURX)2025-12-31$1.10M+261.8%
INVO Fertility, Inc. (IVF)2025-12-31$30.6K+150.6%
OSR Health, Inc. (OSRH)2025-12-31$2.31M-14.9%

Compare LUCD, PMI, INBS, TNON side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗